5-(Hydroxymethyl)-1H-pyrrole-2-carbaldehyde, 95.0%, 1g

Benzyl allyl(2-oxoethyl)carbamate, 95.0%, 250mg

1-Cbz-4-Piperidone, 98.0%, 5g

SPIRO[3.3]HEPTANE-2-CARBOXYLIC ACID, 97.0%, 250mg

2-Bromo-5,6-dichloropyridin-3-amine, 95.0%, 500mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 500 µl, 1750 RN, 1 piece

tert-Butyl ((6-aminopyridin-3-yl)methyl)carbamate, 95%, 100mg

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(naphthalen-1-yl)propanoic acid, 98%, 100mg

4-(Aminomethyl)pyridin-3-ol, 97.0%, 1g

Palladium (0) tetrakis(triphenylphosphine), 98.0%, 10g

(R)-6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide, 98%, 25mg

5-Acetamido-2-methylbenzoic acid, 97%, 25g

Tert-butyl 3-(benzylamino)azetidine-1-carboxylate, 95+%, 250mg